IL13 and cardiovascular disorder: With the capacity to activate both the type I and type II IL-4 receptor, leading to downstream signalling associated with enhanced NADPH oxidase activity29,30, IL-4 may serve as a greater stimulus for macrophage ROS generation than IL-13 in the setting of cardiovascular disease.